|Session Assignment: 709|
|CASPASE-7 ABLATION PROTECTS THE T17M RHODOPSIN MICE FROM SEVERE RETINAL DEGENERATION THROUGH REPROGRAMING OF THE UPR AND INHIBITION OF TRAF2-JNK APOPTOSIS|
|Author: Shreyasi Choudhury||Presenter: Shreyasi Choudhury|
|Department: Cell Biology and Anatomy|
|Research Area: Eye/Vision|
|(1) Caspase 7, (2) Apoptosis, (3) Retinitis pigmentosa|
|1.Shreyasi Choudhury, Department of Cell Biology and Anatomy, University of North Texas Health Science Center, Fort-Worth, Texas 76107 2.Yogesh Bhootada, Department of Cell Biology and Anatomy, University of North Texas Health Science Center, Fort-Worth, Texas 76107 3.Oleg Gorbatyuk,Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida 32610 4.Marina Gorbatyuk, Department of Cell Biology and Anatomy, University of North Texas Health Science Center, Fort-Worth, Texas 76107|
|Short Description: Retinitis pigmentosa (RP) is the most commonly inherited blinding disease, and causes severe visual impairment in as many as 1.5 million people world-wide. The death of the light sensing visual cells is the hallmark of the disease. Although the central vision is preserved until the late stages of RP, peripheral vision is significantly affected. We will be using a mouse model, which closely resembles the human RP disease to better understand and target this disease. Our preliminary data shows that a specific protein, Caspase 7 is significantly activated in the mouse model, that leads to the death of the visual cells. We will remove the Caspase 7 in the mouse model of RP and will study whether their is better survival. We will be studying the molecular signaling mechanisms behind these. We will also develop a virus based carrier system to deliver our caspase-7 inhibitor in the mouse models. Our study has significant bench to bed side translation potential and our carrier system can be used to inhibit caspase-7 in human RP patients, delaying the disease.|
Purpose: We previously demonstrated that misfolded T17M rhodopsin (RHO) activates the Unfolded Protein Response (UPR) in mouse rod photoreceptor cells eventually leading to Autosomal Dominant Retinitis Pigmentosa. We also have shown that the ablation of the UPR-induced CASP-7 in T17M RHO transgenic mice slows down the rate of retinal degeneration measured by ERG and SD-OCT. Therefore, the goal of this study is to elucidate the molecular mechanisms involved in the preservation of vision in T17MRHO CASP7-/- retinas to validate new therapeutic targets
Methods: In vitro and in vivo studies were conducted to elucidate the pathway by which CASP-7 ablation promotes the ADRP photoreceptor cell survival. RNA and protein extracts were obtained from the 661W cells co-transfected with either wt or T17M RHO plasmid and control or CASP-7 siRNA. Retinas were harvested from C57/BL6, T17MRHO, T17MRHO CASP7-/- mice at P30 to perform qRT-PCR and western blot analysis.
Results: The study of the cellular signaling in T17MRHO CASP7-/- retina demonstrated that the preservation of the structure and function of ADRP photoreceptors is occurred via down-regulation of the UPR-induced gene and protein expression. The ATF4, pATF6, mTor and Hif1 proteins were down regulated by 55%, 57%, 31%, 77% correspondingly and the level of pAKT was elevated by 60% in T17MRHO CASP7-/- retina. In addition, the inhibition of PARP1 and TNFa proteins in T17MRHO CASP7-/- retina was observed. All together these modifications lead to diminishing the TRAF2 and pc-Jun by 31%, 50% correspondingly. In vitro study also confirmed the modulation of cellular signaling observed in T17M RHO CASP7-/- retina.
Conclusions: Both in vivo and in vitro studies indicated that the ablation of CASP-7 in the T17MRHO retina prevents the deterioration of retinal function and structure through reprograming of the UPR and modulation of TRAF2-JNK-induced apoptosis. This reduction is believed to occur through the down-regulation of the mTOR and Hif1a proteins. The inhibition of the PARP1 and TNFa proteins is also found to be responsible for diminishing the TRAF2-JNK apoptosis. In both scenarios, the reduction in c-Jun apoptosis leads to ADRP photoreceptor survival. This study points out c-Jun as a potential therapeutic targets for ADRP treatment.